Table 1.
Results of the primary endpoints (arm pain, decreased mobility, and difficulty in sleeping) for the control group and the PRP (Arthrex ACP) group.
| Arm pain | Decreased mobility | Difficulty in sleeping | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | % | ACP | % | Control | % | ACP | % | Control | % | ACP | % | |
| Never | 68 | 69.4 | 16 | 84.2 | 67 | 68.4 | 16 | 84.2 | 68 | 70.1 | 18 | 90 |
| Rarely | 22 | 22.4 | 3 | 15.8 | 24 | 24.5 | 3 | 15.8 | 16 | 16.5 | 1 | 5 |
| Sometimes | 4 | 4.1 | — | 2 | 2.0 | — | 10 | 10.3 | 1 | 5 | ||
| Most of the time | 3 | 3.1 | — | 4 | 4.1 | — | 3 | 3.1 | — | |||
| Always | 1 | 1.0 | — | 1 | 1.0 | — | — | — | ||||
|
| ||||||||||||
| Total | 98 | 19 | 98 | 19 | 97 | 20 | ||||||
| P | 0.668 | 0.655 | 0.56 | |||||||||